Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/93445
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Cancer pain and opioids - past, present, and future |
Author: | Crawford, G.B. |
Citation: | Oncology & hematology review, 2015; 11(1):56-57 |
Publisher: | Touch Digital Media |
Issue Date: | 2015 |
ISSN: | 2052-3815 2052-3823 |
Statement of Responsibility: | Gregory B Crawford |
Abstract: | The Cancer Council Australia and Cancer Institute New South Wales are two Australian organizations that are providing useful resources to support evidence-based prescribing of opioids in cancer pain. Morphine remains the preeminent medication for nociceptive cancer pain. Our understanding of the action of opioids, and how relatively recently these developments are, assists in putting pain and suffering in the context of “total pain.” Increasing understanding of the how pain is understood is leading to new insights with an increasing emphasis on the neuroimmuno- pharmacology of pain. |
Keywords: | Cancer pain; morphine; opioid conversion; neuro-immuno-pharmacology |
Description: | Editorial |
Rights: | This article is published under the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, adaptation, and reproduction provided the original author(s) and source are given appropriate credit. |
DOI: | 10.17925/OHR.2015.11.01.56 |
Published version: | http://www.touchoncology.com/journals/oncology-hematology-review-us |
Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_93445.pdf | Published version | 631.5 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.